Evidence map›Paper›PMID 39275056›Full record

ArticleMolecules (Basel, Switzerland)2024

Investigating the Promising P28 Peptide-Loaded Chitosan/Ceramic Bone Scaffolds for Bone Regeneration.

Keran Zhou, Bianca Simonassi-Paiva, Gustavo Fehrenbach, Guangming Yan, Alexandre Portela, Robert Pogue, Zhi Cao, Margaret Brennan Fournet, Declan M Devine

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Keran ZhouPRISM Research Institute, Technological University of the Shannon, Midlands Midwest, Athlone Main Campus, N37 HD68 Athlone, Ireland.ORCID 0000-0002-0335-1549
Bianca Simonassi-PaivaPRISM Research Institute, Technological University of the Shannon, Midlands Midwest, Athlone Main Campus, N37 HD68 Athlone, Ireland.ORCID 0000-0002-8486-1275
Gustavo FehrenbachPRISM Research Institute, Technological University of the Shannon, Midlands Midwest, Athlone Main Campus, N37 HD68 Athlone, Ireland.ORCID 0000-0002-9389-3391
Guangming YanPRISM Research Institute, Technological University of the Shannon, Midlands Midwest, Athlone Main Campus, N37 HD68 Athlone, Ireland.ORCID 0000-0003-2765-682X
Alexandre PortelaPRISM Research Institute, Technological University of the Shannon, Midlands Midwest, Athlone Main Campus, N37 HD68 Athlone, Ireland.ORCID 0009-0001-6137-9507
Robert PogueGenomic Sciences and Biotechnology Program, Catholic University of Brasilia, Brasília 71966-700, Brazil.ORCID 0000-0002-8789-3512
Zhi CaoPRISM Research Institute, Technological University of the Shannon, Midlands Midwest, Athlone Main Campus, N37 HD68 Athlone, Ireland.ORCID 0000-0002-6638-8920
Margaret Brennan FournetPRISM Research Institute, Technological University of the Shannon, Midlands Midwest, Athlone Main Campus, N37 HD68 Athlone, Ireland.ORCID 0000-0002-9811-1715
Declan M DevinePRISM Research Institute, Technological University of the Shannon, Midlands Midwest, Athlone Main Campus, N37 HD68 Athlone, Ireland.ORCID 0000-0002-1364-5583

Funding

Enterprise Ireland CF20160600Technological University of the Shannon: Midlands Midwest PC00026
6 · The paper itself

Abstract

Bone has the ability to heal itself; however, bone defects fail to heal once the damage exceeds a critical size. Bone regeneration remains a significant clinical challenge, with autograft considered the ideal bone graft material due to its sufficient porosity, osteogenic cells, and biological growth factors. However, limitations to bone grafting, such as limited bone stock and high resorption rates, have led to a great deal of research into developing bone graft substitutes. The P28 peptide is a small molecule bioactive biomimetic alternative to mimic the bone morphogenetic protein 2 (BMP-2). In this study, we investigated the potential of P28-loaded hybrid scaffolds to mimic the natural bone structure for enhancing the bone regeneration process. We hypothesized that the peptide-loaded scaffolds and nude scaffolds both have the potential to promote bone healing, and the bone healing process is accelerated by the release of the peptide. To verify our hypothesis, C2C12 cells were evaluated for the presence of calcium deposits by histological stain at 7 and 14 days in cultures with hybrid scaffolds. Total RNA was isolated from C2C12 cells cultured with hybrid scaffolds for 7 and 14 days to assess osteoblast differentiation. The project findings demonstrated that the hybrid scaffold could enhance osteoblast differentiation and significantly improve the therapeutic effects of the scaffold in bone regeneration.

Indexed as

Bone RegenerationCell DifferentiationCeramicsChitosanTissue ScaffoldsAnimalsBone Morphogenetic Protein 2Cell LineHumansMiceOsteoblastsOsteogenesisPeptidesTissue EngineeringBone Morphogenetic Protein 2ChitosanPeptidesbone regenerationbone scaffoldbone tissue engineeringosteoblast differentiation

Identifiers

PMID39275056
PMCPMC11396924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.